Protein biomarkers of disease progression in patients with systemic sclerosis associated interstitial lung disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Protein biomarkers of disease progression in patients with systemic sclerosis associated interstitial lung disease ; volume:13 ; number:1 ; day:27 ; month:5 ; year:2023 ; pages:1-9 ; date:12.2023
Scientific reports ; 13, Heft 1 (27.5.2023), 1-9, 12.2023
- Creator
-
Cerro-Chiang, Giuliana
Ayres, Matthew
Rivas, Alejandro
Romero, Tahmineh
Parker, Sarah J.
Mastali, Mitra
Elashoff, David
Chen, Peter
Eyk, Jennifer E. Van
Wolters, Paul J.
Boin, Francesco
Zaman, Tanzira
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-35840-y
- URN
-
urn:nbn:de:101:1-2023091109083033259475
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cerro-Chiang, Giuliana
- Ayres, Matthew
- Rivas, Alejandro
- Romero, Tahmineh
- Parker, Sarah J.
- Mastali, Mitra
- Elashoff, David
- Chen, Peter
- Eyk, Jennifer E. Van
- Wolters, Paul J.
- Boin, Francesco
- Zaman, Tanzira
- SpringerLink (Online service)
Other Objects (12)
Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
Pathogenesis of interstitial lung disease in systemic sclerosis
Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
Systemic sclerosis-associated interstitial lung disease: How to manage in 2024?
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
Macrophages as determinants and regulators of systemic sclerosis-related interstitial lung disease
Extracellular vesicles and interstitial lung disease in systemic sclerosis: State of the art!
CD19 + CD21lo/neg cells are increased in systemic sclerosis-associated interstitial lung disease
Circulating cytokine levels in systemic sclerosis related interstitial lung disease and idiopathic pulmonary fibrosis
Correction to: Detection and Monitoring of Interstitial Lung Disease in Patients with Systemic Sclerosis
Use of artificial intelligence algorithms to analyse systemic sclerosis-interstitial lung disease imaging features
Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
Pathogenesis of interstitial lung disease in systemic sclerosis
Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
Systemic sclerosis-associated interstitial lung disease: How to manage in 2024?
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
Macrophages as determinants and regulators of systemic sclerosis-related interstitial lung disease
Extracellular vesicles and interstitial lung disease in systemic sclerosis: State of the art!
CD19 + CD21lo/neg cells are increased in systemic sclerosis-associated interstitial lung disease
Circulating cytokine levels in systemic sclerosis related interstitial lung disease and idiopathic pulmonary fibrosis
Correction to: Detection and Monitoring of Interstitial Lung Disease in Patients with Systemic Sclerosis
Use of artificial intelligence algorithms to analyse systemic sclerosis-interstitial lung disease imaging features
Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
Pathogenesis of interstitial lung disease in systemic sclerosis
Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
Systemic sclerosis-associated interstitial lung disease: How to manage in 2024?
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
Macrophages as determinants and regulators of systemic sclerosis-related interstitial lung disease
Extracellular vesicles and interstitial lung disease in systemic sclerosis: State of the art!
CD19 + CD21lo/neg cells are increased in systemic sclerosis-associated interstitial lung disease
Circulating cytokine levels in systemic sclerosis related interstitial lung disease and idiopathic pulmonary fibrosis
Correction to: Detection and Monitoring of Interstitial Lung Disease in Patients with Systemic Sclerosis